Bioventix Financials
BVXP Stock | 3,750 40.00 1.08% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Operating Income | 6.3 M | 10.6 M |
|
|
Bioventix | Select Account or Indicator |
Understanding current and past Bioventix Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bioventix's financial statements are interrelated, with each one affecting the others. For example, an increase in Bioventix's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Bioventix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bioventix. Check Bioventix's Beneish M Score to see the likelihood of Bioventix's management manipulating its earnings.
Bioventix Stock Summary
Bioventix competes with JLEN Environmental, Tata Steel, Universal Display, United States, and Martin Marietta. Bioventix is entity of United Kingdom. It is traded as Stock on LSE exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | UK Stock View All |
Exchange | London Exchange |
ISIN | GB00B4QVDF07 |
Business Address | 7 Romans Business |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.bioventix.com |
Phone | 44 12 5272 8001 |
You should never invest in Bioventix without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bioventix Stock, because this is throwing your money away. Analyzing the key information contained in Bioventix's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Bioventix Key Financial Ratios
There are many critical financial ratios that Bioventix's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bioventix reports annually and quarterly.Revenue | 13.61 M | ||||
Gross Profit | 11.01 M | ||||
EBITDA | 10.74 M | ||||
Net Income | 8.1 M | ||||
Total Asset | 13.73 M |
Bioventix Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 13.3M | 12.9M | 13.1M | 13.3M | 13.7M | 8.2M | |
Other Current Liab | 311.1K | 315.9K | 385.8K | 412.7K | 375.1K | 201.8K | |
Accounts Payable | 96.1K | 150.9K | 157.3K | 77.7K | 170.0K | 178.5K | |
Cash | 8.1M | 6.5M | 6.1M | 5.7M | 6.0M | 4.3M | |
Net Receivables | 639.0K | 638.1K | 754.0K | 1.2M | 6.2M | 6.5M | |
Inventory | 245.4K | 332.5K | 461.8K | 565.4K | 615.3K | 646.1K | |
Other Current Assets | 3.0M | 4.0M | 4.5M | 4.6M | 5.3M | 5.6M | |
Total Liab | 778.9K | 1.1M | 1.3M | 1.2M | 1.7M | 881.9K | |
Common Stock | 257.1K | 260.4K | 260.5K | 261.0K | 300.1K | 223.0K | |
Retained Earnings | 10.9M | 10.2M | 10.2M | 10.3M | 10.3M | 7.3M | |
Net Debt | (8.1M) | (6.5M) | (6.1M) | (5.7M) | (6.0M) | (6.3M) | |
Total Current Assets | 12.0M | 11.5M | 11.8M | 12.1M | 12.8M | 9.5M | |
Net Tangible Assets | 10.8M | 12.5M | 11.8M | 11.8M | 13.6M | 10.8M | |
Other Liab | 30.9K | 50.2K | 78.1K | 44.3K | 50.9K | 39.1K | |
Net Invested Capital | 12.5M | 11.8M | 11.8M | 12.1M | 13.9M | 12.6M | |
Net Working Capital | 11.2M | 10.4M | 10.6M | 10.9M | 12.5M | 11.4M |
Bioventix Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (6.1K) | (87.0K) | (129.4K) | (103.6K) | (50.0K) | (52.5K) | |
Change In Cash | 1.5M | (1.6M) | (368.3K) | (410.8K) | 283.1K | 265.7K | |
Free Cash Flow | 7.4M | 6.1M | 7.5M | 7.9M | 8.5M | 5.0M | |
Depreciation | 133.6K | 135.1K | 143.4K | 129.2K | 113.6K | 84.2K | |
Other Non Cash Items | (159.5K) | 220.1K | 184.8K | 36.7K | 718.1K | 754.0K | |
Dividends Paid | 6.5M | (7.7M) | (7.9M) | (8.4M) | (8.2M) | (7.8M) | |
Capital Expenditures | 339.6K | 260.3K | 11.8K | 10.6K | 15.9K | 15.1K | |
Net Income | 7.2M | 6.7M | 7.7M | 8.4M | 8.1M | 5.2M | |
End Period Cash Flow | 8.1M | 6.5M | 6.1M | 5.7M | 6.0M | 5.6M | |
Investments | (221.7K) | (229.2K) | (7.0K) | 90.5K | 104.1K | 109.3K | |
Change To Netincome | (4.4K) | (65.7K) | 475.0K | 391.3K | 450.0K | 472.5K |
Bioventix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bioventix's current stock value. Our valuation model uses many indicators to compare Bioventix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioventix competition to find correlations between indicators driving Bioventix's intrinsic value. More Info.Bioventix is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bioventix is roughly 1.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioventix's earnings, one of the primary drivers of an investment's value.Bioventix Systematic Risk
Bioventix's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bioventix volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Bioventix correlated with the market. If Beta is less than 0 Bioventix generally moves in the opposite direction as compared to the market. If Bioventix Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bioventix is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bioventix is generally in the same direction as the market. If Beta > 1 Bioventix moves generally in the same direction as, but more than the movement of the benchmark.
Bioventix Total Assets Over Time
Bioventix November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bioventix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bioventix. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bioventix based on widely used predictive technical indicators. In general, we focus on analyzing Bioventix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bioventix's daily price indicators and compare them against related drivers.
Information Ratio | (0.12) | |||
Maximum Drawdown | 15.82 | |||
Value At Risk | (3.80) | |||
Potential Upside | 5.33 |
Additional Tools for Bioventix Stock Analysis
When running Bioventix's price analysis, check to measure Bioventix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventix is operating at the current time. Most of Bioventix's value examination focuses on studying past and present price action to predict the probability of Bioventix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventix's price. Additionally, you may evaluate how the addition of Bioventix to your portfolios can decrease your overall portfolio volatility.